Benefits of hip arthroscopy surgery for soccer players: a systematic review and meta-analysis.

Researchers gathered data from 12 case series involving 361 soccer players who had hip arthroscopy, a minimally invasive surgical procedure used to diagnose and treat hip joint problems. They looked at whether the surgery helped players get better and return to the game. The results showed that after surgery, players reported less pain, better hip function, and improved ability to do everyday activities.

About 91% of players returned to playing soccer, and the average time from surgery back to the pitch was around 6 months. The findings suggest that hip arthroscopy may be a useful option for soccer players dealing with hip injuries, though the research comes mostly from smaller studies rather than large randomized trials.

This research tracked soccer players who had arthroscopic hip surgery to see if it helped them get back to playing. After surgery, players reported their hip pain dropped significantly, and their overall hip function and ability to manage daily tasks both improved quite a bit.

Nine out of every ten players returned to playing soccer, and those who did typically got back to it within about six months. That said, the studies included in this review were all relatively small, so we do not yet have the strongest possible evidence from large, carefully controlled trials.

If you are a soccer player thinking about hip surgery, these results offer some encouragement, but your own situation and your surgeon's advice will matter most.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This meta-analysis pulls together 12 case series (8 rated as high quality, 4 as moderate) documenting functional outcomes in soccer players after hip arthroscopy. The effect sizes on the modified Harris Hip Score, pain reduction, and activities of daily living scores were all statistically significant and appear clinically meaningful.

Return-to-play rates were high at 91%, with a mean time to return of about 6.3 months, and 71% of those who returned did so at their previous performance level. The evidence base remains limited to case series rather than randomized controlled trials, which means we cannot fully isolate the effect of surgery from natural healing, placebo effect, or rehabilitation influence.

The findings are encouraging and consistent across included studies, but clinicians should recognize this as moderate-quality evidence that suggests benefit rather than definitive proof. Further research comparing arthroscopy to non-surgical management or to sham surgery would help clarify the true magnitude of surgical benefit.